Scott Williams sits down with Justine Underhill of Trade VisionTM to discuss Paradigm Biopharmaceuticals’ performance to date, IP protection, and what initially got us interested in the investment.

The information in this video is strictly general in nature and is not advice or based on your personal situation. Do your own research